New Product Briefs: 510(k)s for bioMérieux, Navilyst Medical and Novo Nordisk
This article was originally published in The Gray Sheet
Executive Summary
FDA clears bioMérieux’s Vitek MS system for rapid identification of disease-causing bacteria and yeast in human specimens. Navilyst Medical introduces a second BioFlo device with Endexo thrombus-resistance. More new products.
You may also be interested in...
News Briefs: Boston Sci’s DES Approval; Bard’s Drug-Coated Balloon Submission
Product approvals from Boston Scientific, Bruker and Sorin. Bard completes drug-coated balloon PMA. HHS OIG amends Synthes corporate integrity agreement.
New Paradigms Brewing In Atrial Fibrillation Ablation
Groundbreaking new mapping technologies could shift the future direction of the $2.5 billion AF ablation market, as evidenced by presentations at this year’s HRS and EUROPACE meetings; with some compelling clinical data now on the books, the electrophysiologists who perform AF ablation are taking notice, as are investors and strategics operating in this space. Emerging companies at the heart of this shift include Topera Medical, CardioInsight Technologies, and Acutus Medical.
New Products In Brief
Debuts include Medtronic’s next-generation Arctic Front Advance for paroxysmal atrial fibrillation, Covidien’s iDrive Ultra surgical stapler and AngioDynamics’ BioFlo peripherally inserted central catheters.